GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Vicore Pharma Holding AB (OSTO:VICO BTA) » Definitions » Cyclically Adjusted Book per Share

Vicore Pharma Holding AB (OSTO:VICO BTA) Cyclically Adjusted Book per Share : kr0.00 (As of Mar. 2025)


View and export this data going back to . Start your Free Trial

What is Vicore Pharma Holding AB Cyclically Adjusted Book per Share?

Note: As Cyclically Adjusted Book per Share is a main component used to calculate Cyclically Adjusted PB Ratio. If the month end stock price for this stock is zero, result may not be accurate due to the exchange rate between different shares and the data will not be stored into our database. Selected historical data showed in the calculation section below is only for demostration purpose.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Vicore Pharma Holding AB's adjusted book value per share for the three months ended in Mar. 2025 was kr89.740. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is kr0.00 for the trailing ten years ended in Mar. 2025.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

As of today (2025-07-15), Vicore Pharma Holding AB's current stock price is kr8.00. Vicore Pharma Holding AB's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2025 was kr0.00. Vicore Pharma Holding AB's Cyclically Adjusted PB Ratio of today is .

During the past 12 years, the highest Cyclically Adjusted PB Ratio of Vicore Pharma Holding AB was 3.07. The lowest was 1.02. And the median was 1.32.


Vicore Pharma Holding AB Cyclically Adjusted Book per Share Historical Data

The historical data trend for Vicore Pharma Holding AB's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vicore Pharma Holding AB Cyclically Adjusted Book per Share Chart

Vicore Pharma Holding AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Vicore Pharma Holding AB Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Vicore Pharma Holding AB's Cyclically Adjusted Book per Share

For the Biotechnology subindustry, Vicore Pharma Holding AB's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vicore Pharma Holding AB's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Vicore Pharma Holding AB's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Vicore Pharma Holding AB's Cyclically Adjusted PB Ratio falls into.


;
;

Vicore Pharma Holding AB Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Vicore Pharma Holding AB's adjusted Book Value per Share data for the three months ended in Mar. 2025 was:

Adj_Book= Book Value per Share /CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=89.74/132.8245*132.8245
=89.740

Current CPI (Mar. 2025) = 132.8245.

Vicore Pharma Holding AB Quarterly Data

Book Value per Share CPI Adj_Book
201506 5.411 99.995 7.188
201509 0.000 100.228 0.000
201512 7.206 100.276 9.545
201603 7.066 100.751 9.315
201606 6.947 101.019 9.134
201609 6.808 101.138 8.941
201612 2.778 102.022 3.617
201703 8.965 102.022 11.672
201706 10.664 102.752 13.785
201709 10.516 103.279 13.524
201712 5.064 103.793 6.480
201803 10.311 103.962 13.174
201806 10.761 104.875 13.629
201809 12.721 105.679 15.989
201812 25.107 105.912 31.487
201903 24.606 105.886 30.866
201906 22.316 106.742 27.769
201909 20.341 107.214 25.200
201912 28.287 107.766 34.865
202003 26.059 106.563 32.481
202006 23.989 107.498 29.641
202009 36.238 107.635 44.719
202012 31.182 108.296 38.245
202103 55.339 108.360 67.833
202106 49.186 108.928 59.977
202109 40.689 110.338 48.981
202112 33.716 112.486 39.812
202203 25.615 114.825 29.630
202206 20.061 118.384 22.508
202209 14.135 122.296 15.352
202212 25.427 126.365 26.727
202303 19.755 127.042 20.654
202306 26.573 129.407 27.275
202309 49.828 130.224 50.823
202312 40.055 131.912 40.332
202403 42.997 132.205 43.198
202406 38.260 132.716 38.291
202409 33.225 132.304 33.356
202412 99.334 132.987 99.212
202503 89.740 132.825 89.740

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.


Vicore Pharma Holding AB  (OSTO:VICO BTA) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

During the past 12 years, the highest Cyclically Adjusted PB Ratio of Vicore Pharma Holding AB was 3.07. The lowest was 1.02. And the median was 1.32.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Vicore Pharma Holding AB Cyclically Adjusted Book per Share Related Terms

Thank you for viewing the detailed overview of Vicore Pharma Holding AB's Cyclically Adjusted Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Vicore Pharma Holding AB Business Description

Traded in Other Exchanges
Address
Kornhamnstorg 53, Stockholm, SWE, 111 27
Vicore Pharma Holding AB is a clinical-stage pharmaceutical company focused on severe lung diseases. The company is establishing a portfolio in respiratory diseases, including idiopathic pulmonary fibrosis (IPF). Its C21 is a small molecule angiotensin II type 2 receptor agonist (ATRAG) currently in phase 2b development for IPF. The company also has an investigational medical device in clinical development, namely, Almee, which is a digital therapeutic leveraging cognitive behavioral therapy created to address the psychological impact of living with pulmonary fibrosis.

Vicore Pharma Holding AB Headlines

No Headlines